Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans

Immunology Letters

Volumn 133, Issue 2, 2010, Pages 106-111

  Fragoso, José Manuel ^a,d   Delgadillo, Hilda ^a   Llorente, Luis ^b   Chuquiure, Eduardo ^a   Juárez Cedillo, Teresa ^c   Vallejo, Maite ^a   Lima, Guadalupe ^b   Furuzawa Carballeda, Janette ^b   Peña Duque, Marco Antonio ^a   Martínez Ríos, Marco Antonio ^a   Vargas Alarcón, Gilberto ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Acute coronary syndrome; Genetic susceptibility; Interleukin 1; Myocardial infarction; Polymorphisms

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; PHOSPHODIESTERASE I;

ACUTE CORONARY SYNDROME; ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY RISK; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HISPANIC; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ACUTE CORONARY SYNDROME; AGED; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LINKAGE DISEQUILIBRIUM; MALE; MEXICO; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 77956994284     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.08.003     Document Type: Article

References (30)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
2. Frostegård J., Ulfgren A.K., Nyberg P., Hedin U., Swedenborg J., Andersson U., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999, 145:33-43.
3. Duff G.W. Cytokines and anti-cytokines. Br J Rheumatol 1993, 32:15-20.
4. Arend W.P., Malyak M., Guthridge C.J., Gabay C. Interleukin 1 receptor antagonist: role in biology. Annu Rev Immunol 1998, 16:27-55.
5. Libby P., Warner S.J., Friedman G.B. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 1988, 81:487-498.
6. Di Giovine F.S., Duff G.W. Interleukin 1: the first interleukin. Immunol Today 1990, 11:13-20.
7. Sims J.E., Nicklin M.J., Bazan J.F., Barton J.L., Busfield S.J., Ford J.E., et al. A new nomenclature for IL-1-family genes. Trends Immunol 2001, 22:536-537.
8. Nicklin M.J., Barton J.L., Nguyen M., FitzGerald M.G., Duff G.W., Komman K. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 2002, 79:718-725.
9. Nicklin M.J., Hughes D.E., Barton J.L., Ure J.M., Duff G.W. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 2000, 191:303-312.
10. Ferrari D., Pizzirani C., Adinolfi E., Lemoli R.M., Curti A., Idzko M., et al. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006, 176:3877-3883.
11. Elaraj D.M., Weinreich D.M., Varghese S., Puhlmann M., Hewitt S.M., Carroll N.M., et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin Cancer Res 2006, 12:1088-1096.
12. Iacoviello L., Di Castelnuovo A., Gattone M., Pezzini A., Assanelli D., Lorenzet R., et al. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 2005, 25:222-227.
13. Latkovskis G., Licis N., Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 2004, 31:207-213.
14. Auer J., Weber T., Berent R., Lassnig E., Lamm G., Eber B. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics 2003, 3:317-328.
15. Miller A. A single salting out procedure for extraction DNA from human nucleated cell. Nucleic Acids Res 1998, 16:1215-1217.
16. Timms A.E., Crane A.M., Sims A.M., Cordell H.J., Bradbury L.A., Abbott A., et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 2004, 75:587-595.
17. de Almeida M.C., Silva A.C., Barral A., Barral-Netto M. A simple method for human peripheral blood monocyte isolation. Mem Inst Oswaldo Cruz 2000, 95:221-223.
18. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 2003, 340:115-126.
19. Fan J., Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003, 10:63-71.
20. Getz G.S. Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis. J Lipid Res 2005, 46:1-10.
21. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
22. van Minkelen R., Wettinger S.B., de Visser M.C., Vos H.L., Reitsma P.H., Rosendaal F.R., et al. Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis 2009, 203:201-205.
23. Mignone F., Gissi C., Liuni S., Pesole G. Untranslated regions of mRNAs. Genome Biol 2002, 3:1-10.
24. Bashirullah A., Cooperstock R.L., Lipshitz H.D. Spatial and temporal control of RNA stability. Proc Natl Acad Sci USA 2001, 98:7025-7028.
25. Francis S.E., Camp N.J., Dewberry R.M., Gunn J., Syrris P., Carter N.D., et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999, 99:861-866.
26. Iacoviello L., Donati M.B., Gattone M. Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel disease and myocardial infarction. Circulation 2000, 101:E193.
27. Tolusso B., Pietrapertosa D., Morelli A., De Santis M., Gremese E., Farina G., et al. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics 2006, 7:683-695.
28. Hurme M., Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998, 28:2598-2602.
29. Danis V.A., Millington M., Hyland V.J., Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995, 99:303-310.
30. Vamvakopoulos J., Green C., Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 2002, 32:2988-2996.